143 related articles for article (PubMed ID: 29863243)
1. Decreased expression of miR-1254 is associated with cancer aggressiveness and predicts poor outcome in cervical cancer.
Zhou J; Liu X; Wang CH; Wang D; Du JJ
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2997-3001. PubMed ID: 29863243
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
Yang Y; Song KL; Chang H; Chen L
Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
[TBL] [Abstract][Full Text] [Related]
4. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer.
Wang Q; Qin J; Chen A; Zhou J; Liu J; Cheng J; Qiu J; Zhang J
Tumour Biol; 2015 May; 36(5):3703-8. PubMed ID: 25560490
[TBL] [Abstract][Full Text] [Related]
6. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
7. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
[TBL] [Abstract][Full Text] [Related]
8. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
Fang H; Shuang D; Yi Z; Sheng H; Liu Y
Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-664 in cervical cancer is associated with lower overall survival.
Zhang YX; Qin LL; Yang SY
Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1740-4. PubMed ID: 27212165
[TBL] [Abstract][Full Text] [Related]
10. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of miR-503 is associated with poor prognosis in cervical cancer.
Yin ZL; Wang YL; Ge SF; Guo TT; Wang L; Zheng XM; Liu J
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4081-5. PubMed ID: 26592830
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer.
Chang YH; Yin F; Fan GF; Zhao M
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4045-4049. PubMed ID: 29028098
[TBL] [Abstract][Full Text] [Related]
13. Down-regulated serum microRNA-101 is associated with aggressive progression and poor prognosis of cervical cancer.
Jiang W; Pan JJ; Deng YH; Liang MR; Yao LH
J Gynecol Oncol; 2017 Nov; 28(6):e75. PubMed ID: 29027393
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer.
Shen SN; Wang LF; Jia YF; Hao YQ; Zhang L; Wang H
Diagn Pathol; 2013 Apr; 8():69. PubMed ID: 23631806
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-335 represents an independent prognostic marker in cervical cancer.
Wang C; Jiang T
Tumour Biol; 2015 Aug; 36(8):5825-30. PubMed ID: 25712373
[TBL] [Abstract][Full Text] [Related]
16. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
17. MiR-599 as a potential biomarker for prognosis of glioma.
Zhu XY; Li GX; Liu ZL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):294-298. PubMed ID: 29424886
[TBL] [Abstract][Full Text] [Related]
18. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
Meng FM; Meng FM; Song XL
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer.
Zhang X; Li F; Zhu L
Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
